Is EDIT up or down today?
EDIT is down 6.19% today, last at 3.03. This stock moved -6.19% versus the prior close.
EDIT · EDIT
EDIT (EDIT) is trading at 3.03, down 6.19% on the session. EDIT sits at the 48% mark of its 52-week range, carries a 14-day RSI of 50, and trades above its 50-day average. Over the past month it is up 5.21%.
Leading the coverage: “Seven Fleet Capital Management LP Takes Position in Editas Medicine, Inc. $EDIT - MarketBeat” (Google News Company, 4d ago). EDIT is +2.54% since story.
EDIT trades on a trailing P/E of 42.6 and is running 6.15% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
EDIT is down 6.19% today, last at 3.03. This stock moved -6.19% versus the prior close.
Leading the coverage: “Seven Fleet Capital Management LP Takes Position in Editas Medicine, Inc. $EDIT - MarketBeat” (Google News Company, 4d ago). EDIT is +2.54% since story. Dominant story: Editas Medicine, Inc. SEC Filing (Sep 9, 2026) - Stock Titan (1 source, neutral) RSI is 50 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Editas Medicine, Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Editas Medicine at Wells Fargo conference: a focused bet on CRISPR - Investing.com Canada
A potential gene-editing treatment moves toward trials as Editas adds a veteran with more than 25 years' experience. - Stock Titan
Editas Medicine names Dan Ory as chief medical officer By Investing.com - Investing.com UK
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer